Sort
23,748 grants matching “melanoma”
Targeting Aldehyde Dehydrogenase for Cancer Prevention
$600,507Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Microbial and host biomarkers in colorectal cancer oncogenesis
$600,499Yiping W Han · Columbia University Health Sciences · R01 · FY2025 · CA
BD FACSymphony High Parameter Flow Cytometer
$600,173Manish S Patankar · University Of Wisconsin-Madison · S10 · FY2018 · OD
PD-1/PD-L1 modulation in cancer therapy
$600,140Drew M. Pardoll · Johns Hopkins University · R01 · FY2023 · CA
PD-1/PD-L1 modulation in cancer therapy
$600,140Drew M. Pardoll · Johns Hopkins University · R01 · FY2025 · CA
PD-1/PD-L1 modulation in cancer therapy
$600,139Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$600,058Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Immunotherapy Strategies for Uveal Melanoma
$600,058Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
SWOG Biospecimen Bank
$600,000Nilsa Del Carmen Ramirez · Research Inst Nationwide Children'S Hosp · U24 · FY2018 · CA
High-Throughput DNA Sequencer
$600,000Suzanne Sandmeyer · University Of California-Irvine · S10 · FY2016 · OD
BIOLOGY OF NONMELANOMA SKIN CANCER GROWTH &PROGRESSION
$600,000University Of Texas Md Anderson Can Ctr · P01 · FY2001 · CA
Spectroscopic dye localization: sentinel lymph nodes
$599,958Spectros Corporation · R44 · FY2002 · CA
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
$599,799Timothy S McConnell · Isoplexis, Inc. · R44 · FY2017 · OD
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
$599,799Timothy S McConnell · Isoplexis, Inc. · R44 · FY2018 · OD
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics
$599,799Timothy S McConnell · Isoplexis, Inc. · R44 · FY2019 · OD
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors
$599,573Diana Zepeda-Orozco · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM
$599,508Ronald Walter · Texas State University · R24 · FY2012 · OD
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
$599,504Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2019 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$599,443Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2011 · CA
Tissue Array Research Program
$599,322Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$599,268Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2020 · CA
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$599,268Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2021 · CA
Targeting BPTF in the Therapy of BRAF-mutant Melanoma
$599,119Mohammed Kashani-Sabet · California Pacific Med Ctr Res Institute · R01 · FY2019 · CA
Discovery of Glutaryl-CoA Dehydrogenase inhibitors for melanoma and pancreatic cancer
$599,074Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Mechanisms that couple irregular development of fetal melanoblasts to premature exhaustion of adult melanocyte stem cells
$599,047Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AR